The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Axogen Inc. (AXGN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.25, or 4.63%, to $5.65. The Axogen Inc. has recorded 14,868 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Axogen, Inc. Reports 2023 Third Quarter Financial Results.
Axogen Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. At the end of the last regular session, the stock closed at $5.40 and fluctuated between $5.43 as its day high and $4.89 as its day low. The current market capitalization of Axogen Inc. is $232.09M. A total of 0.6 million shares were traded on the day, compared to an average of 430.91K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AXGN has seen 4 BUY and 0 SELL insider trades, representing the acquisition of 36,000 and the disposition of 0 shares. Over the last 12 months, there were 45 BUYs and 35 SELLs from insiders. Insiders purchased 420,880 shares during that period but sold 224,018.
In the most recent transaction, Wendell Amy McBride bought 10,000 shares of AXGN for 6.22 per share on Sep 06. After the transaction, the Director now owns 80,342 company shares. In a previous transaction on Aug 23, Burke William P. Mr. bought 10,000 shares at 6.56 per share. AXGN shares that Director owns now total 10,000.
Among the insiders who bought shares, NEELS GUIDO J acquired of 10,000 shares on Aug 16 at a per-share price of $6.11. This resulted in the Director holding 68,259 shares of AXGN after the transaction. In another insider transaction, Freitag Gregory Gene sold 41,980 shares at $8.71 per share on Jun 01. Company shares held by the Director now total 290,135.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AXGN in the last 3 months, the mean price target is $11.50 with high estimates of $17.00 and low estimates of $9.00. In terms of 52-week highs and lows, AXGN has a high of $13.66 and a low of $3.45.
As of this writing, AXGN has an earnings estimate of -$0.06 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0 per share and a lower estimate of -$0.13. The company reported an EPS of -$0.1 in the last quarter, which was 28.60% higher than expectations of -$0.14.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AXGN’s latest balance sheet shows that the firm has $84.09M in Cash & Short Term Investments as of fiscal 2021. There were $67.45M in debt and $24.29M in liabilities at the time. Its Book Value Per Share was $2.26, while its Total Shareholder’s Equity was $112.55M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXGN is Buy with a score of 5.00.